Empowering entrepreneurs to foster healthcare innovation

Empowering entrepreneurs/to foster healthcare innovation

Our Focus

At Forbion Capital Partners we invest in Life Sciences and Biomedical Technology companies developing world-class drugs and technologies, with a clear focus on product development. 

The Forbion team is specialized in the evaluation of late stage preclinical and early stage clinical development programs. We focus on companies that have innovative technologies and drug development programs with unique advantages over current treatments. Furthermore, we invest in medical device companies with a special focus on interventional devices in cardiology, gastroenterology and pulmonology that are close to market approval.

Our involvement continues beyond the initial investment. We work closely with scientists, academic institutions, entrepreneurs and industry experts to accelerate the development and to optimize the commercial potential of our portfolio company's products and technologies.

FORBION Capital Partners
True innovation is to create precedent rather than follow it

True innovation is to create precedent rather than follow it

Meet our team

Our People

Our team typically takes a collaborative approach to reviewing transactions that leverage our combined clinical, financial, operational and management expertise.

Follow us LinkedIn
Working closely with scientists, entrepreneurs and academic institutions

Working closely with scientists, entrepreneurs and academic institutions

Show all

Portfolio

Our featured portfolio companies